Oncogenic transcriptional program driven by TAL1 in T-cell acute lymphoblastic leukemia
- PMID: 30145780
- DOI: 10.1007/s12185-018-2518-z
Oncogenic transcriptional program driven by TAL1 in T-cell acute lymphoblastic leukemia
Abstract
TAL1/SCL is a prime example of an oncogenic transcription factor that is abnormally expressed in acute leukemia due to the replacement of regulator elements. This gene has also been recognized as an essential regulator of hematopoiesis. TAL1 expression is strictly regulated in a lineage- and stage-specific manner. Such precise control is crucial for the switching of the transcriptional program. The misexpression of TAL1 in immature thymocytes leads to a widespread series of orchestrated downstream events that affect several different cellular machineries, resulting in a lethal consequence, namely T-cell acute lymphoblastic leukemia (T-ALL). In this article, we will discuss the transcriptional regulatory network and downstream target genes, including protein-coding genes and non-coding RNAs, controlled by TAL1 in normal hematopoiesis and T-cell leukemogenesis.
Keywords: T-cell acute lymphoblastic leukemia; TAL1; Transcription factor.
Similar articles
-
ARID5B as a critical downstream target of the TAL1 complex that activates the oncogenic transcriptional program and promotes T-cell leukemogenesis.Genes Dev. 2017 Dec 1;31(23-24):2343-2360. doi: 10.1101/gad.302646.117. Epub 2018 Jan 11. Genes Dev. 2017. PMID: 29326336 Free PMC article.
-
TAL1 as a master oncogenic transcription factor in T-cell acute lymphoblastic leukemia.Exp Hematol. 2017 Sep;53:7-15. doi: 10.1016/j.exphem.2017.06.001. Epub 2017 Jun 24. Exp Hematol. 2017. PMID: 28652130 Review.
-
Alteration of CTCF-associated chromatin neighborhood inhibits TAL1-driven oncogenic transcription program and leukemogenesis.Nucleic Acids Res. 2020 Apr 6;48(6):3119-3133. doi: 10.1093/nar/gkaa098. Nucleic Acids Res. 2020. PMID: 32086528 Free PMC article.
-
Core transcriptional regulatory circuit controlled by the TAL1 complex in human T cell acute lymphoblastic leukemia.Cancer Cell. 2012 Aug 14;22(2):209-21. doi: 10.1016/j.ccr.2012.06.007. Cancer Cell. 2012. PMID: 22897851 Free PMC article.
-
SCL/TAL1: a multifaceted regulator from blood development to disease.Blood. 2017 Apr 13;129(15):2051-2060. doi: 10.1182/blood-2016-12-754051. Epub 2017 Feb 8. Blood. 2017. PMID: 28179281 Review.
Cited by
-
Identification of rare and pathogenic TAL2 gene mutations in B-lineage acute lymphoblastic leukemia (B-ALL) using mutational screening and comprehensive bioinformatics analysis.Mol Biol Rep. 2025 Jan 16;52(1):125. doi: 10.1007/s11033-025-10229-4. Mol Biol Rep. 2025. PMID: 39821746
-
The Significance of the Intrinsically Disordered Regions for the Functions of the bHLH Transcription Factors.Int J Mol Sci. 2019 Oct 24;20(21):5306. doi: 10.3390/ijms20215306. Int J Mol Sci. 2019. PMID: 31653121 Free PMC article. Review.
-
Loss of thymocyte competition underlies the tumor suppressive functions of the E2a transcription factor in T-ALL.Leukemia. 2024 Mar;38(3):491-501. doi: 10.1038/s41375-023-02123-4. Epub 2023 Dec 28. Leukemia. 2024. PMID: 38155245
-
Molecular subgroups of T-cell acute lymphoblastic leukemia in adults treated according to pediatric-based GMALL protocols.Leukemia. 2024 Jun;38(6):1213-1222. doi: 10.1038/s41375-024-02264-0. Epub 2024 May 14. Leukemia. 2024. PMID: 38744920 Free PMC article.
-
Isoforms of the TAL1 transcription factor have different roles in hematopoiesis and cell growth.PLoS Biol. 2023 Jun 28;21(6):e3002175. doi: 10.1371/journal.pbio.3002175. eCollection 2023 Jun. PLoS Biol. 2023. PMID: 37379322 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous